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Abstract 
 Cryopreservation is a technique that involves freezing living cells to preserve them in 
long-term storage. Freezing and preserving living cells would not be possible without the 
assistance of cryopreservatives. Many cryopreservatives like DMSO and glycerol are currently 
used to protect living cells as they freeze. However, because of potential toxicity and the need for 
washing steps in blood transfusion medicine, there is need for alternative cryopreservatives that 
are both effective and safe for living cells. In this paper, sucralose, an artificial sweetener, is 
tested as a cryopreservative at varying concentrations. In addition, sucralose was paired with a 
traditional cryopreservative, DMSO, to observe if its efficacy was altered. The study showed that 
sucralose does offer cryoprotective ability, and its protection increases as the concentration 
increases. Pairing cryopreservatives was shown to be less effective. Presented data could be 












 Cryopreservation is a means to preserve structurally intact living cells and tissues at very 
low temperatures. Freezing intact living cells cannot be accomplished without the help of 
chemicals called cryoprotective agents (CPAs). Being that liquid water is a requirement for cells 
to survive, it is normal to believe that the freezing and solidification of water in live cells can 
cause cell death (Mazur, 1984). Cell death can be the result of ice crystal formation that pierces 
and destroys the integrity of cellular membranes (Leibo, 1978). Therefore, there is a need for 
CPAs that help the cell survive during freezing by limiting the formation of ice crystals. It has 
been shown that chemicals such as dimethyl sulfoxide (DMSO) and glycerol are effective as 
cryopreservatives (von Bomhard, 2016). However, CPAs like glycerol and DMSO can 
sometimes have toxic effects on cells (Gregory, 2010). For instance, it has been shown that 
glycerol causes shape changes and membrane destabilization of erythrocytes (Bakaltcheva, 
1996). In addition, cryopreservatives like glycerol that are used in transfusion medicine must be 
washed out before transfusions, since they are toxic, plus the process is time-consuming and 
expensive (Lusianti, 2013). Because of the potential toxicity of current CPAs and the need for 
more effective protocols in red blood cell cryopreservation, there exists a need to find alternative 
cryopreservatives that are nontoxic and effective in red blood cell cryopreservation. 
 Sucralose, an artificial sweetener, is a cheap, nontoxic potential alternative to traditional 
cryopreservatives. It has been found that sucralose has the potential to displace water from 
cellular membranes, and therefore may be useful as a cryopreservative	because it could inhibit 
ice crystal formation (Barker, 2017). Sucralose would classify as a non-penetrating 
cryopreservative because its chemical structure inhibits its ability to insert itself into cellular 
membranes. Other non-penetrating cryopreservatives, like hydroxyethyl starch (HES), have been 
found effective in preserving red blood cells (Pogozhykh, 2017). The advantage of using non-
penetrating CPAs is the elimination of the washing step before transfusion (Pogozhkyh, 2017). 
Pogozhkyh also found potential in using a combination of CPAs during freezing and thawing. 
The aim of this research is to test the ability of sucralose as a cryopreservative, and to find if its 
ability to protect is altered if combined with a traditional CPA like DMSO. 
Materials and Experimental Design 
 Defibrillated sheep blood (Hemostat labs, Dixon, CA) was used to supply red blood cells. 
1.5 mL of blood was dispensed into two 15 mL conical tubes and centrifuged at 500 g’s for 5 
minutes at 20 degrees Celsius. The supernatant was removed. The blood was then washed 
multiple times in 150 mM NaCl until the supernatant was completely clear or had a light yellow 
tint. The washes are needed to remove the serum from the blood. Once washed, 1 mL of blood 
from each tube was combined in a new 15 mL conical tube. Then, 1 mL of blood was taken and 
dispensed into a 50 mL conical tube and diluted 50-fold with phosphate buffer saline (PBS) by 
taking the total volume to 50 mL.  At this stage a preliminary red blood cell count was performed 
to ensure there was enough red blood cells in the diluted blood solution. 
 The diluted blood was used in the experiment as the final blood solution. 200 µL of 
diluted blood was added to the desired number of wells in a 96-well plate. Each experiment was 
performed in triplicate so typically 18-24 wells were used. Then, aliquots of sucralose solution, 
PBS, and DMSO if needed, were added to the wells to attain the desired % (w/v). Aliquots were 
divided into multiple additions to ensure that osmotic collapse of the red blood cells did not 
occur. The total volume of each well was 250 µL. Once the well-plate was prepared, it was left at 
room temperature for one hour, then transferred to a -20 °C freezer for one hour, and finally the 
plate was moved to a -80 °C freezer until ready for data collection. Shown below are the aliquots 










Aliquots for RBC Counting Experiment and Hemolysis without DMSO 
Well % (w/v) Sucralose Sucralose added 
(µL) 
PBS added (µL) 
1 0 0 4(12.5) 
2 0.156 1.56 25+12.5+6.25+3.125+1.56 
3 0.313 3.125 25+12.5+6.25+3.125 
4 0.625 2(3.125) 25+3(6.25) 
5 1.25 2(6.25) 3(12.5) 
6 2.5 2(12.5) 2(12.5) 
7 5 4(12.5) 0 
Total Volume in each well = 250 µL 
Aliquots for Hemolysis Experiment with DMSO 




PBS Added (µL) DMSO 
Added (µL) 
     
1 0 0 3(12.5) 12.5 
2 0.156 1.56 2(12.5)+6.25+3.125+1.56 12.5 
3 0.313 3.125 2(12.5)+6.25+3.125 12.5 
4 0.625 6.25 2(12.5)+6.25 12.5 
5 1.25 2(6.25) 2(12.5) 12.5 
6 2.5 2(12.5) 12.5 12.5 
Total Volume in each well = 250 µL 
 
 When ready for analysis, the well-plate was transferred to a 37 °C incubator until thawed. 
The thawing process usually takes 40-60 minutes. If the cells were to be counted, 100 µL of each 
well was mixed with 100 µL of trypan blue solution to dye the cells and then observed under a 
microscope using a hemocytometer. Trypan blue is used because it dyes only dead cells. In these 
experiments, only live cells were counted.  
 To measure hemolysis, a micro-plate reader was utilized to measure the absorbance of 
each well. First, the well-plate was centrifuged until a clear supernatant was observed, and the 
supernatant was pipetted into different wells that corresponded with the original wells. The plate 
was then loaded into the plate reader, and the absorbance was measured at 450 and 492 nm. The 
data from the 450 nm reading was used in the results because hemoglobin has a peak absorbance 
at 420 nm. 
Results 
 
Figure 1: The results in this graph were compiled after following the protocol explained earlier. 
This experiment was executed to test how the concentration of sucralose affected the survival of 
red blood cells after during freezing and thawing. As shown, the number of surviving cells 





















Figure 2: Shown above are average hemolysis results after following the protocol. As the 
concentration of sucralose increases, the % hemolysis decreases, meaning more cellular 
membranes remained intact. However, at higher concentrations of sucralose hemolysis begins to 
increase once more. The 0% concentration of sucralose results are not displayed because the % 




















RBC Hemolysis w/o DMSO
 
Figure 3: Shown above are hemolysis results following protocol, along with the addition of 5% 
(w/v) DMSO in each of the experimental wells. The average results are displayed. Again, as the 
concentration of sucralose increases, the % hemolysis decreases. There is no 5% (w/v) sucralose 
trial in this case, because the addition of 5% (w/v) DMSO would have made the total volume 

























% (w/v) Sucralose % Hemolysis Without DMSO % Hemolysis With DMSO 
0.156 44.38 76.31 
0.313 15.19 35.68 
0.625 18.87 31.57 
1.25 18.10 27.15 
2.5 25.28 27.49 
 
Table 1: Shown above are results compiled to compare the differences in hemolysis percentages 
between the experiments performed with and without the addition of 5% (w/v) DMSO. As 
shown, there was better protection without DMSO present.  
 
Discussion 
 Sucralose does provide some protection during the freezing and thawing process. In most 
of the results, as the concentration of sucralose increases, so does its cryoprotective ability. There 
is to be noted one discrepancy. In the red blood cell counting results, the 5% sucralose 
concentration yielded the most living cells after freezing and thawing. However, in the hemolysis 
results without DMSO addition, the 5% sucralose concentration yielded a higher hemolysis rate 
than lower concentrations of sucralose. Therefore, it could be that higher concentrations of 
sucralose can become toxic to cells, or there could be some error in the experiment to account for 
the discrepancy. 
 The combination of sucralose and DMSO was less effective than sucralose alone, 
although the same trend mentioned above did follow, which further supports that sucralose offers 
protection during the freezing and thawing process. The best hemolysis rate in the experiments 
came at 0.313 % (w/v) of sucralose and conferred a 15.19 % hemolysis rate. 
 
Conclusion and Future Experimentation 
 There is evidence to conclude that sucralose does offer protection for red blood cells 
during the freezing and thawing process. Its protection is likely to be best when not paired with 
penetrating CPAs like DMSO. However, there are some changes in protocol that could be made 
to increase the efficacy of sucralose as a cryopreservative. For instance, there is room to fine tune 
the optimal sucralose concentration by testing intermediate concentrations between those that 
were used in these experiments. Other freezing protocols like droplet freezing and rate freezing 
may prove more effective than the freezing protocol used here. There also is room for expansion 
in pairing sucralose with other cryopreservatives, although using penetrative CPAs would likely 
show the same results as the ones presented here. Finally, while these results show cell survival 
and hemolysis rates, they do not show that red blood cells are viable after freezing and thawing. 
Therefore, experimentation analyzing the viability of red blood cells after freezing by utilizing an 
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